Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis

Key Points

• Compounds exhibit anti-Shigella activity, targeting the pathogen effectively for treatment.
• The study reveals distinct killing kinetics, helping to understand how quickly the compounds work.
• Assessment involves screening compounds from MMV Pathogen and COVID Boxes to identify potential leads.
• This work supports the need for new treatments against shigellosis, a significant public health concern.